Manabe Ichiro, Shindo Takayuki, Nagai Ryozo
Department of Cardiovascular Medicine, University of Tokyo, Tokyo, Japan.
Circ Res. 2002 Dec 13;91(12):1103-13. doi: 10.1161/01.res.0000046452.67724.b8.
Structural remodeling of the ventricular wall is a key determinant of clinical outcome in heart disease. Such remodeling involves the production and destruction of extracellular matrix proteins, cell proliferation and migration, and apoptotic and necrotic cell death. Cardiac fibroblasts are crucially involved in these processes, producing growth factors and cytokines that act as autocrine and paracrine factors, as well as extracellular matrix proteins and proteinases. Recent studies have shown that the interactions between cardiac fibroblasts and cardiomyocytes are essential for the progression of cardiac remodeling. This review addresses the functional role played by cardiac fibroblasts and the molecular mechanisms that govern their activity during cardiac hypertrophy and remodeling. A particular focus is the recent progress toward our understanding of the transcriptional regulatory mechanisms involved.
心室壁的结构重塑是心脏病临床预后的关键决定因素。这种重塑涉及细胞外基质蛋白的产生和破坏、细胞增殖与迁移以及凋亡和坏死性细胞死亡。心脏成纤维细胞在这些过程中起着至关重要的作用,它们产生作为自分泌和旁分泌因子的生长因子和细胞因子,以及细胞外基质蛋白和蛋白酶。最近的研究表明,心脏成纤维细胞与心肌细胞之间的相互作用对于心脏重塑的进展至关重要。本文综述了心脏成纤维细胞所起的功能作用以及在心脏肥大和重塑过程中调控其活性的分子机制。特别关注的是我们在理解相关转录调控机制方面的最新进展。